MEI Pharma Announces Expansion of Phase 1b Study Evaluating Zandelisib and Clinical Pipeline Update ...Middle East

SAN DIEGO, Jan. 4, 2021 /PRNewswire/ -- MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that the Phase 1b trial arm exploring zandelisib, an investigational selective phosphatidylinositol 3-kinase ("PI3K")...

Read More Details
Finally We wish PressBee provided you with enough information of ( MEI Pharma Announces Expansion of Phase 1b Study Evaluating Zandelisib and Clinical Pipeline Update )

Also on site :

• Gold miners killed in pit collapse in war-torn Sudan
• This Week on 'Beyond the Gates' Welcome to Fairmont Crest
• Gautam Gambhir punishes Yashasvi Jaiswal, takes ruthless call after his fielding errors in 1st Test